At Gradian Diagnostics We Specialize In Advising Privately Held Medical Device, Diagnostic And Surgical Instrument Companies On How To Successfully Raise Capital And Grow Their Operations In The USA.
Gradian Diagnostics invests time and effort understanding the companies it partners with and leverages its financial market expertise and vast network of sources of capital to negotiate the most beneficial terms when raising funds.
After assessing potential and development stage, we guide our partners through the right type of funding, either private equity, private placement or IPO. Post financing, we help our partners achieve an optimal financial structure to boost growth and continue to prepare them for the next stage of financing or towards a successful exit.
We collaborate with our partners to accelerate growth by leveraging our business network, operational expertise and go-to market experience, helping them to find licensing and joint venture opportunities and to improve their competitive position in the US market.
Seeking the right fit.
Mission: we believe people’s health is the cornerstone of a prosperous society and thus, we partner up with innovative companies that tackle real medical issues.
Synergy: we look for companies that can truly leverage our expertise and that are ready to engage in real collaboration to produce exceptional outcomes.
Looking to the future.
Impactful: making a difference means setting up ambitious goals that tackle real problems.
Long-term- we understand how present-day financing and organizational decision-making impacts the future value of high growth companies.
Our forthright communication and focus on unequivocal collaboration are the fundamentals upon which we build exceptional partnerships.
We believe inspiration must always be backed up by heavy dose of quantitative evidence.
We follow a pragmatic approach towards investing, supporting our decision making on factual data to deliver the best long-term returns.
Healthcare providers and governments are placing increasing emphasis on early detection to improve people’s lives and reduce healthcare costs. Gradian Diagnostics supports companies developing exciting new technologies, from point-of-care testing to lab automation, allowing them to raise capital in the best terms.
Demand for quality healthcare and technological advance is pushing the med tech industry into a territory of unlimited opportunities. Our years of hands-on expertise in medical devices allow us to provide innovative companies with an insider viewpoint, so they can achieve their maximum potential.
Molzym manufactures ultra-clean and highly active amplification reagents and kits for microbial nucleic acid extraction from a variety of specimens. In particular, reagents and consumables are supplied free of contaminating microbial DNA – guaranteed lot by lot. Our customers appreciate the ability of increasing the number of amplification cycles and thus lowering the limit of detection dramatically without false positive results arising from contaminating microbial DNA. Another core expertise is Molzym’s unique technology of the depletion of human DNA, a well-known factor negatively influencing sensitive PCR and microbiome analysis at low microbial loads.
firstname.lastname@example.org+1 (917) 482 9254
9 Island AvenueMiami Beach, Florida 33131
email@example.com+ 43 660 8309 111
Fluchtgasse 6/7A-1090 Wien
© 2019 Gradian Diagnostics. All Rights Reserved